|
|
|
| home > white papers > Maximize the ROI of Your Post-Approval Research - Bioclinica |
|
|
 WHITE PAPERS |
|
|
Bioclinica
|
|
Maximize the ROI of Your Post-Approval Research
|
|
Expenditures in post-approval (Phase IV) research are going up across
the pharmaceutical, biotech and medical device industries. Given the
resources you’ve committed to post-approval research, you may be
wondering if you’re getting the greatest possible return on your
investment.
Discover how to harness the power of post-approval
research to increase data collection, reduce resource burn, save money,
and maximize your ROI!
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
The key to tackling drug development complexity: Collaboration.
Laupheim and Ravensburg, Germany, Milford, MA, and Skokie, IL, USA, July
6, 2020 – Vetter and Rentschler Biopharma, two globally operating
Contract Development and Manufacturing Organizations (CDMOs), today
announced their strategic collaboration, to enhance their services and
offer complementary skills and experience along the biopharmaceutical
value chain. With drug development growing increasingly complex and
cost-intensive, biopharmaceutical companies are under significant
pressure to streamline their products’ path to market. The desired goal
of the collaboration is to create long-term value through the alignment
of manufacturing approaches that enable clients to bring their products
to patients more easily and faster.
More info >> |
|
 |
White Papers |
 |
|
Data Technology as a Catalyst for Growth in the Life Sciences
AIGENPULSE
The life sciences industry is changing at a rapid pace. The need to develop the next blockbuster is pushing current technologies and methodologies to the limit. Scientific advancement over the last decades was embossed with giant leaps in knowledge, however, the new reality is that smaller incremental gains need to be carved out with ever increasing investments. In order to survive, progress and prosper in this new reality, a holistic approach to getting the most of research data is crucial. In fact, it will likely be the difference of being in existence in 5-10 years or not. For those bold enough to step into an area they are unfamiliar with, huge rewards are waiting.
More info >> |
|
 |
Industry Events |
 |
World Vaccine Congress Europe
18-21 October 2020, Barcelona, Spain
The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >> |
|
|
|
